GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Healthcare Corp (AMEX:NHC) » Definitions » ROE %

National Healthcare (National Healthcare) ROE %

: 12.67% (As of Dec. 2023)
View and export this data going back to 1987. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. National Healthcare's annualized net income for the quarter that ended in Dec. 2023 was $114 Mil. National Healthcare's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $897 Mil. Therefore, National Healthcare's annualized ROE % for the quarter that ended in Dec. 2023 was 12.67%.

The historical rank and industry rank for National Healthcare's ROE % or its related term are showing as below:

NHC' s ROE % Range Over the Past 10 Years
Min: 2.53   Med: 7.78   Max: 16.32
Current: 7.54

During the past 13 years, National Healthcare's highest ROE % was 16.32%. The lowest was 2.53%. And the median was 7.78%.

NHC's ROE % is ranked better than
58.06% of 608 companies
in the Healthcare Providers & Services industry
Industry Median: 4.115 vs NHC: 7.54

National Healthcare ROE % Historical Data

The historical data trend for National Healthcare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.02 5.32 16.32 2.53 7.49

National Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 5.35 7.40 4.70 12.67

Competitive Comparison

For the Medical Care Facilities subindustry, National Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Healthcare ROE % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, National Healthcare's ROE % distribution charts can be found below:

* The bar in red indicates where National Healthcare's ROE % falls into.



National Healthcare ROE % Calculation

National Healthcare's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=66.798/( (874.276+908.752)/ 2 )
=66.798/891.514
=7.49 %

National Healthcare's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=113.624/( (885.171+908.752)/ 2 )
=113.624/896.9615
=12.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


National Healthcare  (AMEX:NHC) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=113.624/896.9615
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(113.624 / 1203.656)*(1203.656 / 1296.3515)*(1296.3515 / 896.9615)
=Net Margin %*Asset Turnover*Equity Multiplier
=9.44 %*0.9285*1.4453
=ROA %*Equity Multiplier
=8.77 %*1.4453
=12.67 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=113.624/896.9615
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (113.624 / 146.66) * (146.66 / 80.704) * (80.704 / 1203.656) * (1203.656 / 1296.3515) * (1296.3515 / 896.9615)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7747 * 1.8173 * 6.7 % * 0.9285 * 1.4453
=12.67 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


National Healthcare ROE % Related Terms

Thank you for viewing the detailed overview of National Healthcare's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


National Healthcare (National Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
100 East Vine Street, Murfreesboro, TN, USA, 37130
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
Executives
Emil E Hassan director
Robert G Adams director, officer: Sr. Vice President & COO P.O. BOX 1398, MURFREESBORO TN 37133-1398
James Paul Abernathy director 2102 GREENLAND DRIVE, MURFREESBORO TN 37130
W Andrew Adams director, officer: CEO P.O. BOX 1398, MURFREESBORO TN 37133-1398
Laroche Richard F Jr director P.O. BOX 1398, MURFREESBORO TN 37133-1398
Burgess Ernest G Iii director P.O. BOX 1398, MURFREESBORO TN 37133-1398
Sandra Y. Trail director 100 VINE STREET, MURFREESBORO TN 37130
Robert Michael Ussery officer: Senior V.P., Operations 100 VINE STREET, SUITE 1400, P. O. BOX 1398, MURFREESBORO TN 37130
Vicki L Dodson officer: Sr.VP Patient Srvcs & CNO 100 VINE STREET, MURFREESBORO TN 37130
Josh A Mccreary officer: Senior VP & General Counsel 100 VINE STREET, MURFREESBORO TN 37130
John K Lines officer: Senior V.P. & General Counsel 601 S. HARBOUR ISLAND BLVD., SUITE 220, TAMPA FL 33602
Jeffrey Russell Smith officer: SVP & Treasurer 100 VINE ST., MURFREESBORO TN 37130
Mcintosh Leroy E. Jr. officer: SVP, Ancillary Services 100 VINE STREET, MURFREESBORO TN 37130
Julia W Powell officer: Sr. V.P., Patient Services 3712 LASCASSAS PIKE, MURFREESBORO TN 37130
Flatt Ben Anderson Sr officer: Senior VP & CIO 100 VINE STREET, MURFREESBORO TN 37130